Dentsply Sirona Welcomes Daniel Scavilla as New CEO
Dentsply Sirona Welcomes Daniel Scavilla as New CEO
Dentsply Sirona Inc. has appointed Daniel Scavilla as its new Chief Executive Officer. An accomplished leader with over thirty years in the medical technology and pharmaceutical sectors, Mr. Scavilla is set to step into his role on August 1, 2025. His extensive background in business leadership positions him ideally to succeed Simon Campion, who has decided to leave the company.
Career Highlights of Daniel Scavilla
Previously, Mr. Scavilla was at the helm of Globus Medical, where he successfully orchestrated the acquisition of NuVasive, significantly expanding the organization’s footprint in the spine technology market. His leadership helped position Globus Medical as a key player in the medical device industry. His robust experience includes nearly three decades with Johnson & Johnson, where he excelled in various financial and operational management roles.
Vision for Dentsply Sirona's Future
Chairman Gregory T. Lucier expressed confidence in Mr. Scavilla, stating that his appointment reflects the Board’s unwavering commitment to shareholder value and future success. With a clear focus on commercial growth, product innovation, and operational excellence, Mr. Scavilla is recognized as the right leader to drive transformative changes within Dentsply Sirona.
Remarks from Mr. Scavilla
Mr. Scavilla shared his enthusiasm for leading Dentsply Sirona, highlighting his admiration for the company’s trusted brands and immense potential. He emphasized the importance of enhancing the company’s performance and ensuring sustained profitable growth across all areas of the organization.
Transition of Leadership and Acknowledgments
As Simon Campion prepares to depart from the company, he reflects on the strong foundation laid during his tenure, expressing confidence in Mr. Scavilla’s leadership abilities. Campion will also step down from the Board, allowing Mr. Scavilla to continue serving as a company director to ensure a seamless leadership transition.
Financial Outlook for Dentsply Sirona
Dentsply Sirona is also set to release preliminary financial results for the second quarter, estimating net sales of about $935 million and adjusted earnings per share ranging between $0.50 and $0.52. The company reaffirmed its outlook for the year, indicating a steady path forward despite the ever-changing market dynamics.
About Dentsply Sirona
Dentsply Sirona stands as a leader in the dental industry, recognized as the largest diversified manufacturer of professional dental products globally. The company boasts over a century of innovation and dedication to providing a comprehensive range of dental solutions, which include high-quality products that enhance patient care. Dentsply Sirona continues to develop groundbreaking technologies aimed at improving dental health and safety standards worldwide. Headquartered in Charlotte, North Carolina, the company trades under the symbol XRAY on the Nasdaq.
Contact Dentsply Sirona
For investor inquiries, you can reach:
Andrea Daley
Vice President, Investor Relations
Phone: +1-704-591-8631
Email: InvestorRelations@dentsplysirona.com
For press-related questions, please contact:
Marion Par-Weixlberger
Vice President, Public Relations & Corporate Communications
Phone: +43 676 848414588
Email: marion.par-weixlberger@dentsplysirona.com
Frequently Asked Questions
Who is the new CEO of Dentsply Sirona?
The new CEO is Daniel Scavilla, who will take over on August 1, 2025.
What is Daniel Scavilla's background?
Mr. Scavilla has over 30 years of experience in the medical technology and pharmaceutical industries, previously serving as CEO of Globus Medical.
What financial performance is Dentsply Sirona expecting for Q2?
The company expects approximately $935 million in net sales with adjusted earnings per share of $0.50 to $0.52.
What will happen to Simon Campion?
Simon Campion will leave the company and step down from the Board, making way for Mr. Scavilla to lead.
Where is Dentsply Sirona headquartered?
Dentsply Sirona is headquartered in Charlotte, North Carolina, and is actively involved in enhancing dental health solutions worldwide.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.